Comparison between Sahajanand Medical Technologies IPO and SISCOL IPO.
Sahajanand Medical Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while SISCOL IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Sahajanand Medical Technologies IPO is up to ₹0.00 Cr whereas the issue size of the SISCOL IPO is up to ₹0.00 Cr. The final issue price of Sahajanand Medical Technologies IPO is and of SISCOL IPO is .
| Sahajanand Medical Technologies IPO | SISCOL IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹96.00 Cr |
| OFS Issue Size | 2,76,44,231 shares | 1,42,40,473 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,76,44,231 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Sahajanand Medical Technologies IPO opens on , while SISCOL IPO opens on . The closing date of Sahajanand Medical Technologies IPO and SISCOL IPO is , and , respectively.
Sahajanand Medical Technologies IPO P/E ratio is , as compared to SISCOL IPO P/E ratio of .
| Sahajanand Medical Technologies IPO | SISCOL IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Sahajanand Medical Technologies Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 442% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Steel Infra Solutions Co.Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 33% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 40.92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 3.68% | 15.16% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.37% | 23.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 3.73% | 15.16% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sahajanand Medical Technologies IPO Retail Individual Investors (RII) are offered 0 shares while in SISCOL IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Sahajanand Medical Technologies IPO and 0 shares in SISCOL IPO.
| Sahajanand Medical Technologies IPO | SISCOL IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Sahajanand Medical Technologies IPO subscribed in total, whereas SISCOL IPO subscribed .
